This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shivapurkar, N. Articles by Gazdar, A. F. Search for Related Content PubMed PubMed Citation Articles by Shivapurkar, N. Articles by Gazdar, A. F.

Multiple Regions of Chromosome 4 Demonstrating Allelic Losses in Breast Carcinomas¹

Hamon Center for Therapeutic Oncology Research [N. S., S. S., I. I. W., A. K. V., A. M., J. D. M., A. F. G.] and Departments of Pathology [A. K. V., A. M., S. M., A. F. G.], Internal Medicine [J. D. M.], and Pharmacology [J. D. M.], University of Texas Southwestern Medical Center, Dallas, Texas 75235

Allelotyping studies suggest that allelic losses at one or both arms of chromosome 4 are frequent in several tumor types, but information about breast cancer is scant. A recent comparative genomic hybridization analysis revealed frequent losses of chromosome 4 in breast carcinomas. In an effort to more precisely locate the putative tumor suppressor gene(s) on chromosome 4 involved in the pathogenesis of breast carcinomas, we performed loss of heterozygosity studies using 19 polymorphic microsatellite markers. After precise microdissection of archival surgical cases, we analyzed DNA obtained from 44 breast carcinomas for loss of heterozygosity. In addition, DNA from tumor cell lines derived from 14 of these 44 breast carcinomas were also analyzed. We observed deletions of chromosome 4 at multiple sites in both tumor cell lines and breast carcinomas. The deletions in cell lines and their corresponding tumors were extensive in nature, whereas they were more localized in noncultured breast carcinomas. The localized deletions in the noncultured breast carcinomas clearly defined four nonoverlapping regions of frequent deletions: 4q33–34 (76%); 4q25–26 (63%); 4p15.1–15.3 (57%); and 4p16.3 (50%). Our results suggest that there may be multiple putative tumor suppressor genes, located on both arms of chromosome 4, whose inactivation is important in the pathogenesis of breast cancer.

This article has been cited by other articles:

				J. Russo, S. V. Fernandez, P. A. Russo, R. Fernbaugh, F. S. Sheriff, H. M. Lareef, J. Garber, and I. H. Russo 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells FASEB J, August 1, 2006; 20(10): 1622 - 1634. [Abstract] [Full Text] [PDF]

				J. L. Edwards and M. A. Apicella The Molecular Mechanisms Used by Neisseria gonorrhoeae To Initiate Infection Differ between Men and Women Clin. Microbiol. Rev., October 1, 2004; 17(4): 965 - 981. [Abstract] [Full Text] [PDF]

				L. Zhang, O. Gjoerup, and T. M. Roberts The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling PNAS, July 13, 2004; 101(28): 10296 - 10301. [Abstract] [Full Text] [PDF]

				F. Marini, N. Kim, A. Schuffert, and R. D. Wood POLN, a Nuclear PolA Family DNA Polymerase Homologous to the DNA Cross-link Sensitivity Protein Mus308 J. Biol. Chem., August 22, 2003; 278(34): 32014 - 32019. [Abstract] [Full Text] [PDF]

				A. Dallol, D. Morton, E. R. Maher, and F. Latif SLIT2 Axon Guidance Molecule Is Frequently Inactivated in Colorectal Cancer and Suppresses Growth of Colorectal Carcinoma Cells Cancer Res., March 1, 2003; 63(5): 1054 - 1058. [Abstract] [Full Text] [PDF]

				A. Dallol, N. F. Da Silva, P. Viacava, J. D. Minna, I. Bieche, E. R. Maher, and F. Latif SLIT2, a Human Homologue of the Drosophila Slit2 Gene, Has Tumor Suppressor Activity and Is Frequently Inactivated in Lung and Breast Cancers Cancer Res., October 15, 2002; 62(20): 5874 - 5880. [Abstract] [Full Text] [PDF]

				P. S. Rudland, A. Platt-Higgins, M. El-Tanani, S. de Silva Rudland, R. Barraclough, J. H. R. Winstanley, R. Howitt, and C. R. West Prognostic Significance of the Metastasis-associated Protein Osteopontin in Human Breast Cancer Cancer Res., June 1, 2002; 62(12): 3417 - 3427. [Abstract] [Full Text] [PDF]

				R. Pero, F. Lembo, D. Di Vizio, A. Boccia, P. Chieffi, M. Fedele, G. M. Pierantoni, P. Rossi, R. Iuliano, M. Santoro, et al. RNF4 Is a Growth Inhibitor Expressed in Germ Cells but Not in Human Testicular Tumors Am. J. Pathol., October 1, 2001; 159(4): 1225 - 1230. [Abstract] [Full Text]

				I. I. Wistuba, M. Tang, A. Maitra, H. Alvarez, P. Troncoso, F. Pimentel, and A. F. Gazdar Genome-wide Allelotyping Analysis Reveals Multiple Sites of Allelic Loss in Gallbladder Carcinoma Cancer Res., May 1, 2001; 61(9): 3795 - 3800. [Abstract] [Full Text]